Correlation Between Enfusion and LivePerson
Can any of the company-specific risk be diversified away by investing in both Enfusion and LivePerson at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enfusion and LivePerson into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enfusion and LivePerson, you can compare the effects of market volatilities on Enfusion and LivePerson and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enfusion with a short position of LivePerson. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enfusion and LivePerson.
Diversification Opportunities for Enfusion and LivePerson
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Enfusion and LivePerson is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and LivePerson in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LivePerson and Enfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enfusion are associated (or correlated) with LivePerson. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LivePerson has no effect on the direction of Enfusion i.e., Enfusion and LivePerson go up and down completely randomly.
Pair Corralation between Enfusion and LivePerson
Given the investment horizon of 90 days Enfusion is expected to generate 0.28 times more return on investment than LivePerson. However, Enfusion is 3.51 times less risky than LivePerson. It trades about 0.31 of its potential returns per unit of risk. LivePerson is currently generating about -0.22 per unit of risk. If you would invest 916.00 in Enfusion on August 27, 2024 and sell it today you would earn a total of 120.00 from holding Enfusion or generate 13.1% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Enfusion vs. LivePerson
Performance |
Timeline |
Enfusion |
LivePerson |
Enfusion and LivePerson Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enfusion and LivePerson
The main advantage of trading using opposite Enfusion and LivePerson positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enfusion position performs unexpectedly, LivePerson can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LivePerson will offset losses from the drop in LivePerson's long position.Enfusion vs. ON24 Inc | Enfusion vs. Paycor HCM | Enfusion vs. E2open Parent Holdings | Enfusion vs. Braze Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |